Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model
暂无分享,去创建一个
C. Mercer | T. Roberts | P. White | A. Sutton | C. Estcourt | R. Birger | J. Saunders
[1] M. Price,et al. Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established , 2017, The Journal of infectious diseases.
[2] P. White,et al. Estimating Local Chlamydia Incidence and Prevalence Using Surveillance Data , 2017, Epidemiology.
[3] Anne M Johnson,et al. The Ballseye programme: a mixed-methods programme of research in traditional sexual health and alternative community settings to improve the sexual health of men in the UK , 2016 .
[4] M. Cusini,et al. Background review for the 2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] M. Cusini,et al. 2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.
[6] Stephen D. Bentley,et al. Genomic Analysis and Comparison of Two Gonorrhea Outbreaks , 2016, mBio.
[7] M. Ieven,et al. Evaluation of the Bio-Rad Dx CT/NG/MG® assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urine , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[8] Marc Lipsitch,et al. Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling. , 2016, The Journal of infectious diseases.
[9] M. Price,et al. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. , 2016, Health technology assessment.
[10] T. Smieszek,et al. Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design , 2016, PloS one.
[11] J. Hocking,et al. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] A. Rowhani-Rahbar,et al. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] L. Manhart. Diagnostic and resistance testing for Mycoplasma genitalium: what will it take? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] E. Adams,et al. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! , 2014, Current opinion in infectious diseases.
[15] C. Carder,et al. A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London , 2014, BMJ Open.
[16] H. Ward,et al. How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review , 2014, Theoretical Biology and Medical Modelling.
[17] Anne M Johnson,et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal) , 2013, The Lancet.
[18] R. Hayes,et al. Natural history of Mycoplasma genitalium Infection in a Cohort of Female Sex Workers in Kampala, Uganda , 2013, Sexually transmitted diseases.
[19] A. Sullivan,et al. 2012 BASHH statement on partner notification for sexually transmissible infections , 2013, International journal of STD & AIDS.
[20] J. Kaldor,et al. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] S. Osser,et al. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. , 2012, American journal of obstetrics and gynecology.
[22] C. Mercer,et al. Where do young men want to access STI screening? A stratified random probability sample survey of young men in Great Britain , 2012, Sexually Transmitted Infections.
[23] C. Morrison,et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women , 2012, AIDS.
[24] C. Mcgowin,et al. Mycoplasma genitalium: An Emerging Cause of Sexually Transmitted Disease in Women , 2011, PLoS pathogens.
[25] S. Kerry,et al. Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] D. Taylor-Robinson,et al. Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis , 2010, Sexually Transmitted Infections.
[27] A. Sullivan,et al. National audit of asymptomatic screening in UK genitourinary medicine clinics: clinic policies audit , 2010, International journal of STD & AIDS.
[28] J. Baseman,et al. Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads , 2010, International journal of STD & AIDS.
[29] K. Persson,et al. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy , 2010, BJOG : an international journal of obstetrics and gynaecology.
[30] L. Manhart. Has the time come to systematically test for Mycoplasma genitalium? , 2009, Sexually transmitted diseases.
[31] Catherine H Mercer,et al. Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk. , 2009, International journal of epidemiology.
[32] C. Fairley,et al. Persistence of Mycoplasma genitalium Following Azithromycin Therapy , 2008, PloS one.
[33] H. Moi,et al. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study , 2008, International journal of STD & AIDS.
[34] S. Birkelund,et al. Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. , 2008, Fertility and sterility.
[35] S. Kelsey,et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease , 2008, Sexually Transmitted Infections.
[36] F. Radebe,et al. The burden of asymptomatic sexually transmitted infections among men in Carletonville, South Africa: implications for syndromic management , 2008, Sexually Transmitted Infections.
[37] J. Jensen,et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial , 2007, Sexually Transmitted Infections.
[38] W. Edmunds,et al. The cost effectiveness of opportunistic chlamydia screening in England , 2007, Sexually Transmitted Infections.
[39] Anne M Johnson,et al. How much do delayed healthcare seeking, delayed care provision, and diversion from primary care contribute to the transmission of STIs? , 2007, Sexually Transmitted Infections.
[40] T. Hallett,et al. Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation , 2007, Sexually Transmitted Infections.
[41] M. Beksinska,et al. Microbicide Applicators: Understanding Design Preferences Among Women in the Dominican Republic and South Africa , 2007, Sexually transmitted diseases.
[42] W. Edmunds,et al. Modelling the effectiveness of chlamydia screening in England , 2006, Sexually Transmitted Infections.
[43] F. Olesen,et al. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population , 2006, Sexually Transmitted Infections.
[44] A. Meier,et al. Mycoplasma genitalium Infection and Persistence in a Cohort of Female Sex Workers in Nairobi, Kenya , 2006, Sexually transmitted diseases.
[45] J. Jensen,et al. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment , 2006, Sexually Transmitted Infections.
[46] S. Garland,et al. Azithromycin Failure in Mycoplasma genitalium Urethritis , 2006, Emerging infectious diseases.
[47] R. Ness,et al. Mycoplasma Genitalium Among Women With Nongonococcal, Nonchlamydial Pelvic Inflammatory Disease , 2006, Infectious diseases in obstetrics and gynecology.
[48] Anne M Johnson,et al. Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database , 2006, BMJ : British Medical Journal.
[49] J. Jensen,et al. Mycoplasma genitalium: prevalence, clinical significance, and transmission , 2005, Sexually Transmitted Infections.
[50] Catherine H Mercer,et al. Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. , 2005, The Journal of infectious diseases.
[51] M. Yasuda,et al. Mycoplasma genitalium urethritis in men. , 2004, International journal of antimicrobial agents.
[52] J. Jensen,et al. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis , 2004, Sexually Transmitted Infections.
[53] J. Jensen,et al. Comparison of First Void Urine and Urogenital Swab Specimens for Detection of Mycoplasma genitalium and Chlamydia trachomatis by Polymerase Chain Reaction in Patients Attending a Sexually Transmitted Disease Clinic , 2004, Sexually transmitted diseases.
[54] R. Venezia,et al. Comparison of Multiplex PCR Assay with Culture for Detection of Genital Mycoplasmas , 2004, Journal of Clinical Microbiology.
[55] J. Jensen. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.
[56] R Smith,et al. Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction , 2004, Journal of Medical Genetics.
[57] J. Cassell,et al. Partner notification in primary care , 2003, Sexually transmitted infections.
[58] K. Fenton,et al. Surveillance of sexually transmitted infections in primary care , 2003, Sexually transmitted infections.
[59] C. Mercer,et al. Treating sexually transmitted infections in primary care: a missed opportunity? , 2003, Sexually transmitted infections.
[60] K. Holmes,et al. Mucopurulent cervicitis and Mycoplasma genitalium. , 2003, The Journal of infectious diseases.
[61] T. Mroczkowski,et al. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] K. Holmes,et al. Association between Mycoplasma genitalium and acute endometritis , 2002, The Lancet.
[63] Wendy Macdowall,et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours , 2001, The Lancet.
[64] S. Birkelund,et al. Serological investigation of Mycoplasma genitalium in infertile women. , 2001, Human reproduction.
[65] D. Taylor-Robinson,et al. The role of Mycoplasma genitalium in non-gonococcal urethritis , 2001, Sexually transmitted infections.
[66] A. Renton,et al. The association of Chlamydia trachomatis and Mycoplasma genitalium with non-gonococcal urethritis: observations on heterosexual men and their female partners , 2000, International journal of STD & AIDS.
[67] J. D. Stratton,et al. Self-reported sexual activity and condom use among symptomatic clients attending STD clinics. , 1999, Sexually transmitted diseases.
[68] W. Levine,et al. The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[69] J. Fortenberry,et al. Health care seeking behaviors related to sexually transmitted diseases among adolescents. , 1997, American journal of public health.
[70] T. Quinn,et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. , 1996, JAMA.
[71] L. Westrom. Effect of pelvic inflammatory disease on fertility. , 1995, Venereology : official publication of the National Venereology Council of Australia.
[72] Hadi Dowlatabadi,et al. Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .
[73] W. Lv. Sexually transmitted diseases and infertility. , 1994 .
[74] W. Cates,et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility , 1993, American journal of obstetrics and gynecology.
[75] C. Dolea,et al. World Health Organization , 1949, International Organization.
[76] J. Spiece,et al. Background Review , 2019, Springer Theses.
[77] M. Cusini,et al. European guideline on Mycoplasma genitalium infections , 2016 .
[78] L. Weström. Sexually transmitted diseases and infertility. , 1994, Sexually transmitted diseases.